Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

Author： Jope Richard   Yuskaitis Christopher   Beurel Eléonore  

Publisher： Springer Publishing Company

ISSN： 0364-3190

Source： Neurochemical Research, Vol.32, Iss.4-5, 2007-04, pp. : 577-595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Roles of Glycogen Synthase Kinase 3 in Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 9, Iss. 7, 2012-09 ,pp. : 864-879

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen synthase kinase-3β (GSK-3β) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus–mediated neurotoxicity in primary human neurons

By Nguyen Timothy B   Lucero Ginger R   Chana Gursharan   Hult Britta J   Tatro Erick T   Masliah Eliezer   Grant Igor   Achim Cristian L   Everall Ian P  

Journal of NeuroVirology, Vol. 15, Iss. 5-6, 2009-12 ,pp. : 434-438

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Immunohistochemical Localization of Glycogen Synthase and GSK3β: Control of Glycogen Content in Retina

By PérezLeón Jorge  

Neurochemical Research, Vol. 38, Iss. 5, 2013-05 ,pp. : 1063-1069

Springer Publishing Company

Access to resources Recommend Favorite

Developmental expression and localization of glycogen synthase kinase-3 in rat brain

By Leroy K.   Brion J.-P.  

Journal of Chemical Neuroanatomy, Vol. 16, Iss. 4, 1999-06 ,pp. : 279-293

Elsevier

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 in Neurodegeneration and Neuroprotection:Lessons from Lithium

By  

Current Alzheimer Research, Vol. 4, Iss. 1, 2007-02 ,pp. : 21-31

Bentham Science Publishers

Access to resources Recommend Favorite